# Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes

> **NCT06435156** · PHASE2 · RECRUITING · sponsor: **University of Dundee** · enrollment: 320 (estimated)

## Conditions studied

- Type 1 Diabetes
- Heart Failure

## Interventions

- **DRUG:** Sotagliflozin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06435156
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-28
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06435156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06435156, "Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06435156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*